Explore the most recent data on proton therapy. While the 2023 NAPT Member Survey is exclusive to NAPT members, to ensure that critical industry insights reach a wider audience an Executive Summary is now publicly available. This essential companion piece empowers policymakers, media and healthcare professionals to review the latest trends and challenges in proton therapy. By shedding light on the state of the industry, we not only inform the public but also promote discussions that can potentially influence critical policy changes and enhance patient care.
A Growing Industry: Proton therapy witnessed a 176% patient increase from 2013 to 2022.
Changing Landscape: Patients now seek proton therapy more frequently after previous radiation treatment.
Diverse Centers: Proton therapy centers exhibit a wide range of affiliations, non-profit models, and variable treatment rooms.
Evolving Conditions: The mix of treated conditions continues to transform.
Barriers to Care: While we make strides, administrative obstacles and delays persist, primarily due to prior authorization processes.
The findings of the 2023 NAPT Member Survey show growth of proton therapy, despite it representing less than 1% of radiation oncology treatments. This is a testament to proton therapy’s efficacy in cancer care. However, it also underscores the critical need to address accessibility challenges within the industry. As we explore the insights from the Member Survey, we recognize the importance of improving patient access, addressing issues like insurance coverage, and expanding the availability of proton therapy centers. The survey’s data aligns with the industry’s commitment to advancing cancer care and highlights the ongoing efforts to make proton therapy more accessible for a broader range of patients.
Empower yourself with the latest industry knowledge and join the conversation!
Download the Executive Summary in the NAPT Resource Center or learn more about NAPT membership, granting you access to the full report.